Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Esophageal cancer patients' need for information and support in making a treatment decision between standard surgery and active surveillance.
Hermus M, van der Wilk BJ, Chang R, Dekker JWT, Coene PLO, Nieuwenhuijzen GAP, Rosman C, Heisterkamp J, Hartgrink HH, Timmermans L, Wijnhoven BPL, van der Zijden CJ, van Lanschot JJB, Busschbach J, Lagarde SM, Kranenburg LW. Hermus M, et al. Cancer Med. 2023 Aug;12(16):17266-17272. doi: 10.1002/cam4.6308. Epub 2023 Jul 1. Cancer Med. 2023. PMID: 37392175 Free PMC article.
Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO-study.
Hermus M, van der Wilk BJ, Chang RTH, Collee G, Noordman BJ, Coene PLO, Dekker JWT, Hartgrink HH, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Timmermans L, Wijnhoven BPL, van der Zijden CJ, Busschbach JJ, van Lanschot JJB, Lagarde SM, Kranenburg LW. Hermus M, et al. Int J Cancer. 2023 Mar 15;152(6):1183-1190. doi: 10.1002/ijc.34327. Epub 2022 Oct 27. Int J Cancer. 2023. PMID: 36250325 Free PMC article.
A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2.
van der Zijden CJ, Lagarde SM, Hermus M, Kranenburg LW, van Lanschot JJB, Mostert B, Nuyttens JJME, Oudijk L, van der Sluis PC, Spaander MCW, Valkema MJ, Valkema R, Wijnhoven BPL; SANO-2 study group. van der Zijden CJ, et al. Among authors: hermus m. BMC Cancer. 2023 Apr 10;23(1):327. doi: 10.1186/s12885-023-10747-z. BMC Cancer. 2023. PMID: 37038138 Free PMC article.
Surgeon's steering behaviour towards patients to participate in a cluster randomised trial on active surveillance for oesophageal cancer: A qualitative study.
de Veer MR, Hermus M, van der Zijden CJ, van der Wilk BJ, Wijnhoven BPL, Stiggelbout AM, Dekker JWT, Coene PPLO, Busschbach JJ, van Lanschot JJB, Lagarde SM, Kranenburg LW. de Veer MR, et al. Among authors: hermus m. Eur J Surg Oncol. 2023 Oct;49(10):106935. doi: 10.1016/j.ejso.2023.05.010. Epub 2023 May 16. Eur J Surg Oncol. 2023. PMID: 37210275 Free article. Clinical Trial.
Developing an e-learning tool for clinicians to take patient preferences into account in esophageal cancer treatment decision-making.
Hermus M, van der Wilk BJ, Dekker JWT, Nieuwenhuijzen GAP, Rosman C, Timmermans L, Wijnhoven BPL, van der Zijden CJ, van Lanschot JJB, Busschbach JJ, Lagarde SM, Kranenburg LW. Hermus M, et al. Health Sci Rep. 2023 Dec 18;6(12):e1725. doi: 10.1002/hsr2.1725. eCollection 2023 Dec. Health Sci Rep. 2023. PMID: 38111742 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 38182849
41 results